However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
Mechanistically, neuronal death protection from autophagy seems to involve the MET downstream mTOR signaling, whose activation (phosphorylation) is enhanced after tMCAO (Shang et al., 2010)
This co-administration strategy is a major focus of clinical trials today, moving these peptides from alternative medicine into supportive medicine [7, 8]
Giugliano D, Scappaticcio L, Longo M et al
Over time, many clients notice improvements in sleep quality, reduced afternoon energy crashes, and a greater sense of physical and mental resilience throughout the day
Morrison RT et al